Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-I tax transgenic mice

Journal of Clinical Investigation

Volumn 98, Issue 2, 1996, Pages 271-278

  Fujisawa, Koushi ^a   Asahara, Hiroshi ^a   Okamoto, Kazuyoshi ^a   Aono, Hiroyuki ^a   Hasunuma, Tomoko ^a   Kobata, Tetsuji ^a   Iwakura, Yoichiro ^b   Yonehara, Shin ^c   Sumida, Takayuki ^a   Nishioka, Kusuki ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

anti Fas mAb; apoptosis; Fas; HTLV I tax; rheumatoid arthritis

Indexed keywords

FAS ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FIBROBLAST; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOHISTOCHEMISTRY; INTRAARTICULAR DRUG ADMINISTRATION; MONONUCLEAR CELL; MOUSE; NEUTROPHIL; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVITIS; SYNOVIUM; TRANSGENIC MOUSE;

EID: 9344241398     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118789     Document Type: Article

References (31)

1. Harris, E.D.J. 1990. Rheumatoid arthritis. Pathophysiology and implications for therapy. N. Engl. J. Med. 322:1277-1289.
2. Nakajima, T., H. Aono, T. Hasunuma, K. Yamamoto, T. Shirai, K. Hirohata, and K. Nishioka. 1995. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum. 38:485-491.
3. Firestein, G.S., M. Yeo, and N.J. Zvaifler. 1995. Apoptosis in rheumatoid arthritis synovium. J. Clin. Invest. 96:1631-1638.
4. Hoa, T.T.M., T. Hasunuma, H. Aono, K. Masuko, T. Kobata, K. Yamamoto, T. Sumida, and K. Nishioka. Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J. Rheumatol. In press.
5. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S.I. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66: 233-243.
6. Watanabe-Fukunaga, R., C.I. Brannan, N. Itoh, S. Yonehara, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1274-1279.
7. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B.C. Trauth, H. Ponsting, and P.H. Krammer. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence similarity with the Fas antigen. J. Biol. Chem. 267:10709-10715.
8. Yonehara, S., A., Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747-1756.
9. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1169-1178.
10. Trauth, B.C., C. Klas, A.M.J. Peters, S. Matzku, P. Möller, W. Falk, K. Debatin, and P.H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (Wash. DC). 245:301-305.
11. Iwakura, Y., M. Tosu, E. Yoshida, M. Takiguchi, K. Sato, I. Kitajima, K. Nishioka, K. Yamamoto, T. Takeda, M. Hatanaka, H. Yamamoto, and T. Sekiguchi. 1991. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science (Wash. DC). 253:1026-1028.
12. Yamamoto, H., T. Sekiguchi, K. Itagaki, S. Saijo, and Y. Iwakura. 1993. Inflammatory polyarthritis in mice transgenic for human T cell leukemia virus type I. Arthritis Rheum. 36:1612-1620.
13. Iwakura, Y., S. Saijo, Y. Kioka, J. Nakayama-Yamada, K. Inagaki, M. Tosu, M. Asano, Y. Kanai, and K. Kakimoto. 1995. Autoimmunity induction by human T cell leukemia virus type I in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. J. Immunol. 155:1588-1598.
14. Gavrich, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
15. Hinuma, Y., K. Nagata, M. Hanaoka, M. Nakai, T. Matsumoto, K. Kinoshita, S. Shirakawa, and I. Miyoshi. 1981. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in the human sera. Proc. Natl. Acad. Sci. USA. 78:6476-6480.
16. Gessain, A., F. Barin, J.C. Vernant, O. Gout, L. Maurs, and G. Calender. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. ii:407-410.
17. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet. i:1031-1032.
18. Kitajima, I., I. Maruyama, S. Maruyama, S. Ijichi, N. Eiraku, Y. Miura, and M. Osame. 1989. Polyarthritis in human T lymphotropic virus type I-associated myelopathy. Arthritis Rheum. 32:1342-1344.
19. Nishioka, K., I. Maruyama, K. Sato, I. Kitajima, T. Nakajima, and M. Osame. 1989. Chronic inflammatory arthropathy associated with HTLV-1. Lancet. i:441.
20. Sagawa, K., M. Mochizuki, K. Masuoka, K., Katagiri, T. Katayama, T. Maeda, A. Tanimoto, S. Sugita, T. Watanabe, and K. Itoh. 1995. Immunopathological mechanisms of human T cell lymphotropic virus type I (HTLV-I) uveitis. Detection of HTLV-I-infected T cell in the eye and their constitutive cytokine production. J. Clin. Invest. 95:852-858.
21. Green, J.E., S.H. Hinrich, J. Vogel, and G. Jay. 1989. Endocrinopathy resembling Sjögren's syndrome in HTLV-I tax transgenic mice. Nature (Lond.). 341:72-74.
22. Terada, K., S. Katamine, K. Eguchi, R. Moriuchi, M. Kita, H. Shimada, I. Yamashita, K. Iwata, Y. Tsuji, S. Nagataki, and T. Miyamoto. 1994. Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. Lancet. 344:1115-1119.
23. Maruyama, M., H. Shibuya, H. Harada, M. Halakeyama, M. Seiki, T. Fujita, J. Inoue, M. Yoshida, and T. Taniguchi. 1987. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-I encoded p40x and T3/Ti complex triggering. Cell. 48:343-350.
24. Cross, S.L., M.B. Feinberg, J.B. Wolf, N.J. Holbrook, F. Wong-Staal, and W.J. Leonard. 1987. Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell 49:47-56.
25. Arai, N., D. Nomura, D. Villaret, R.D. Malefijt, M. Seiki, M. Yoshida, M. Fukuyama, M. Maekawa, J. Kudoh, N. Shimizu et al. 1989. Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J. Immunol. 142:274-282.
26. Yamada, T., S. Yamaoka, T. Goto, M. Nakai, Y. Tsujimoto, and M. Hatanaka. 1994. The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein. J. Virology. 68:3374-3379.
27. Chlichlia, K., G. Moldenhauer, P. Daniel, M. Busslinger, L. Gazzolo, V. Schirrmacher, and K. Khazaie. 1995. Immediate effects of reversible HTLV-I tax function: T-cell activation and apoptosis. Oncogene. 10:269-277.
28. Watanabe-Fukunaga, R., C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.). 356:314-317.
29. Takahashi, T., M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:969-976.
30. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature (Lond.). 364:806-809.
31. Nishimura, Y., A. Ishi, Y. Kobayashi, Y. Yamazaki, and S. Yonehara. 1995. Expression and function of mouse Fas antigen on immature and mature T cells. J. Immunol 154:4395-4403.